CenterBook Partners’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$565K Buy
13,938
+6,535
+88% +$318K 0.03% 613
2026
Q2
$388K Sell
7,403
-31,222
-81% -$1.22M 0.02% 575
2026
Q1
$1.37M Buy
+38,625
New +$1.2M 0.07% 301
2025
Q4
– Sell
-27,928
Closed -$838K – 551
2025
Q3
$838K Buy
27,928
+6,579
+31% +$186K 0.04% 406
2025
Q2
$611K Buy
+21,349
New +$635K 0.03% 403

Other funds holding ALKS

CenterBook Partners's ALKS Position: Q3 2026 in Review

CenterBook Partners increased its Alkermes (ALKS) stake by 88% in Q3 2026, buying an estimated $318K and bringing the position to 13,938 shares worth $565K. The position accounts for 0.03% of the portfolio, ranked #613.

CenterBook Partners first reported a position in ALKS in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.37M in Q1 2026. 112 funds tracked by Wall St. Rank hold ALKS as of Q3 2026.

  • CenterBook Partners held 13,938 shares of Alkermes worth $565K as of Q3 2026.
  • CenterBook Partners bought 6,535 Alkermes shares in Q3 2026, an estimated $318K.
  • Alkermes made up 0.03% of CenterBook Partners's portfolio in Q3 2026, its #613 holding.
  • CenterBook Partners first reported a position in Alkermes in Q2 2025 and has held it in 5 quarters since.
  • CenterBook Partners's Alkermes position peaked at $1.37M in Q1 2026.
  • 112 funds tracked by Wall St. Rank held Alkermes as of Q3 2026.

Based on CenterBook Partners's 13F filing for Q3 2026, filed 2 Nov 2026.